CED-9 Activators
CED-9 activators represent a class of compounds that have garnered significant interest in the field of molecular biology and cell biology due to their pivotal role in the regulation of apoptosis, a programmed cell death process essential for maintaining tissue homeostasis and preventing the proliferation of damaged or abnormal cells. The term CED-9 activators derives from their ability to modulate the activity of the CED-9 protein, which plays a central role in the apoptotic pathway in the nematode Caenorhabditis elegans. CED-9, an ortholog of the mammalian B-cell lymphoma 2 (Bcl-2) protein, functions as a key regulator of apoptosis by inhibiting the activation of downstream pro-apoptotic factors. CED-9 activators are small molecules or ligands that interact with CED-9, ultimately influencing its function and impacting the delicate balance between cell survival and apoptosis.
The mechanism of action of CED-9 activators primarily involves binding to CED-9, leading to conformational changes that either enhance or attenuate its inhibitory activity. By modulating CED-9, these compounds can regulate the release of pro-apoptotic factors such as cytochrome c from the mitochondria, thereby influencing the initiation of apoptosis. The study of CED-9 activators has not only deepened our understanding of the fundamental principles governing cell fate decisions but has also provided valuable insights into the evolutionarily conserved mechanisms that underlie apoptosis in multicellular organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. It can indirectly affect the CED-9 pathway by disrupting signaling pathways that regulate apoptosis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is an anti-cancer drug that can directly induce apoptosis in cells. It forms DNA adducts and triggers DNA damage responses, leading to apoptotic signaling. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
Bcl-2 Inhibitors like ABT-199 can directly target Bcl-2 family proteins, promoting apoptosis by disrupting the balance between pro-apoptotic and anti-apoptotic Bcl-2 family members, including CED-9. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin induces endoplasmic reticulum (ER) stress, which can activate unfolded protein response pathways. ER stress-induced apoptosis can indirectly impact CED-9 signaling. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is an anti-cancer drug that can directly induce apoptosis in cells by intercalating with DNA and inhibiting topoisomerase II. The DNA damage response can activate apoptotic pathways, potentially influencing CED-9. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, which can lead to the accumulation of misfolded or damaged proteins. This can trigger apoptosis indirectly by causing cellular stress and mitochondrial dysfunction, potentially affecting the CED-9 pathway. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide generates oxidative stress, which can damage cellular components, including DNA and mitochondria. This damage can lead to apoptotic signaling pathways that intersect with CED-9 regulation. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A can indirectly influence apoptosis by targeting the mitochondrial permeability transition pore (MPTP) and modulating mitochondrial function. This modulation of mitochondrial pathways can impact CED-9 regulation. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
Valinomycin disrupts mitochondrial function and can lead to the release of pro-apoptotic factors from mitochondria, indirectly affecting the CED-9 pathway by altering mitochondrial dynamics. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 inhibits MDM2, which negatively regulates the p53 tumor suppressor. In C. elegans, there are p53-like genes that may participate in apoptosis regulation. Nutlin-3 can indirectly impact the CED-9 pathway by affecting p53-related signaling. | ||||||